Yvonne Bombard: Scaling access to precision medicine with Genetics Adviser
Yvonne Bombard shared a post by Elissa Levin, Founder of Elissa Levin Precision Medicine Innovation Consulting, on LinkedIn, adding the following:
“I may be biased but I agree! Genetics Adviser is growing! Join us to scale access to precision medicine. Genetics Adviser is the trusted digital platform that adapts to the diverse needs of patients, healthcare providers, and industry partners, facilitating high patient and clinician activation.
Delivering Precision Medicine + Genomics at scale with digital health.”
Quoting Elissa Levin’s post:
“Great opportunity to work an in incredible team!”
Yvonne Bombard is a Canada Research Chair at Unity Health Toronto and a Professor at the University of Toronto. She is also the CEO and Co-Founder of Genetics Adviser and a Research Scientist at the Li Ka Shing Knowledge Institute, St. Michael’s Hospital. Her research interests include genomics, health services, and policy research.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023